0
0
Scientists have made a monumental discovery, identifying over 40,000 previously unknown gut microbes within African populations. This breakthrough, led by the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at the University of the Witwatersrand, South Africa, is poised to dramatically alter how medicines are developed and administered globally.
The research directly addresses a significant gap in microbiome studies, which have historically overlooked the diverse populations of Africa. “The long-term goal is to be able to translate a lot of this into real life. We want to make sure that when medicines are made, as many people as possible are counted,” stated researcher Ovokeraye Oduaran.
Why This Matters:
For decades, pharmaceutical development has predominantly relied on research conducted in high-income countries. However, the gut microbiome, consisting of the trillions of microorganisms residing in the digestive system, plays a crucial role in processing medications. Given that African populations possess distinct gut bacteria compared to those in Europe or America, the efficacy of many drugs may vary significantly.
The findings, published in the journal Nature, suggest that treatments tailored to the unique gut microbiomes of African individuals could be developed. “That’s how important these studies are and it gives you that power to be able to make that decision,” said Luicer Ingasia Olubayo, a Sydney Brenner Charitable Trust postdoctoral fellow at SBIMB. She added that doctors might need to prescribe different medications or supplement treatments with probiotics for African patients.
Surprising Discoveries:
The SBIMB team identified over 1,000 new bacteria species and more than 40,000 new viruses within the gut microbiomes of the study participants. “We found a lot of novelties,” Olubayo explained. “Certain bacteria that were rare on other continents were plentiful in Africa.”
The research involved analyzing stool samples from approximately 1,800 women across Kenya, Ghana, Burkina Faso, and South Africa, utilizing advanced genetic sequencing technology.
New Hope for HIV Treatment:
A particularly exciting discovery was the identification of unique gut bacteria patterns in individuals with HIV. “Had we not done this study, we would not have found this unique microbial signature linked to HIV infection,” Olubayo emphasized, noting that these patterns differed significantly from those observed in HIV patients in wealthier nations. This discovery could pave the way for improved detection, monitoring, and treatment of HIV in African populations.
This study represents the largest investigation of the microbiomes of women living with HIV, underscoring the necessity of region-specific research.
City vs. Rural Life:
The study also revealed that individuals residing in rural areas exhibited richer, more diverse gut bacteria compared to urban dwellers. Urban participants often lacked the bacterium Treponema, likely due to lower fiber intake and increased antibiotic use.
Charissa Naidoo, co-director of the African Microbiome Institute, cautioned that beneficial gut bacteria are diminishing as more Africans adopt urban lifestyles and antibiotic use increases. “Urgent action, such as through nutritional intervention, is needed to preserve gut microbiome diversity in the era of antibiotic overuse,” she warned.
The researchers also found significant variations in gut bacteria even between different cities, highlighting the influence of local diets, environmental factors, and cultural practices.
Filling the Blank Spots:
Despite the Human Microbiome Project’s global ambitions, African populations have been significantly underrepresented. “If you look at the map of the world and plot how many population-based studies have been done, Africa is ending up to be blank, so we’re happy that we are able to paint the African map as well,” Olubayo said.
The researchers are now expanding their work to explore connections between gut bacteria and other health conditions, including sleep disorders, menopause, and neurological diseases.
Jerolen Naidoo, senior researcher in bioengineering and integrative genomics at the Council of Scientific and Industrial Research, emphasized the study’s significance as the first large-scale, African-led investigation of its kind. “These findings represent a watershed moment for the African human microbiome by highlighting the scale of novel biodiversity that still exists within African microbiomes,” he stated, calling for more equitable representation of this diversity in global resources.
Disclaimer: This news article is based on information provided from the source material. While every effort has been made to ensure accuracy, readers should consult with healthcare professionals for medical advice. Research in microbiome studies is ongoing, and future studies may provide further insights.
